KINETIC-STUDY OF SMOKING MARIJUANA

被引:38
作者
BARNETT, G
CHIANG, CWN
PEREZREYES, M
OWENS, SM
机构
[1] UNIV N CAROLINA, SCH MED, CHAPEL HILL, NC 27514 USA
[2] UNIV ARIZONA, SCH PHARM, TUCSON, AZ 85721 USA
来源
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 1982年 / 10卷 / 05期
关键词
D O I
10.1007/BF01059033
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Six subjects each smoked a 1% marijuana and 2 h later smoked a 2nd one. Plasma levels of .DELTA.9 tetrahydrocannabinol were measured for 9 h with a radioimmunoassay. Heart rate and self-reported high were measured for 2 h after each cigarette. All 3 measures showed a rapid increase after the start of smoking, with Cmax [maximum concentration] occurring before the end of smoking. There was a strong correlation between decrease in heart rate and plasma levels from 10 min after smoking until 120 min. All pharmacodynamic response measures returned to baseline values within .apprx. 2 h.
引用
收藏
页码:495 / 506
页数:12
相关论文
共 14 条
[1]   INTERACTIONS OF DELTA-1-TETRAHYDROCANNABINOL WITH CANNABINOL AND CANNABIDIOL FOLLOWING ORAL-ADMINISTRATION IN MAN - ASSAY OF CANNABINOL AND CANNABIDIOL BY MASS FRAGMENTOGRAPHY [J].
AGURELL, S ;
CARLSSON, S ;
LINDGREN, JE ;
OHLSSON, A ;
GILLESPIE, H ;
HOLLISTER, L .
EXPERIENTIA, 1981, 37 (10) :1090-1092
[2]  
BERMAN M, 1977, USERS MANUAL SIMULAT
[3]  
HALLDIN MM, 1982, ARZNEIMITTEL-FORSCH, V32-2, P764
[4]  
HALLDIN MM, 1982, ARZNEIMITTEL-FORSCH, V32-2, P1135
[5]   CONSTITUENTS OF CANNABIS-SATIVA L .11. CANNABIDIOL AND CANNABICHROMENE IN SAMPLES OF KNOWN GEOGRAPHICAL ORIGIN [J].
HOLLEY, JH ;
HADLEY, KW ;
TURNER, CE .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1975, 64 (05) :892-895
[6]  
HUNT CA, 1980, J PHARMACOL EXP THER, V215, P35
[7]   EVIDENCE THAT CANNABIDIOL DOES NOT SIGNIFICANTLY ALTER THE PHARMACOKINETICS OF TETRAHYDROCANNABINOL IN MAN [J].
HUNT, CA ;
JONES, RT ;
HERNING, RI ;
BACHMAN, J .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1981, 9 (03) :245-260
[8]   CLINICAL EFFECTS AND PLASMA-LEVELS OF DELTA-9-TETRAHYDROCANNABINOL (DELTA-9-THC) IN HEAVY AND LIGHT USERS OF CANNABIS [J].
LINDGREN, JE ;
OHLSSON, A ;
AGURELL, S ;
HOLLISTER, L ;
GILLESPIE, H .
PSYCHOPHARMACOLOGY, 1981, 74 (03) :208-212
[9]   PLASMA DELTA-9-TETRAHYDROCANNABINOL CONCENTRATIONS AND CLINICAL EFFECTS AFTER ORAL AND INTRAVENOUS ADMINISTRATION AND SMOKING [J].
OHLSSON, A ;
LINDGREN, JE ;
WAHLEN, A ;
AGURELL, S ;
HOLLISTER, LE ;
GILLESPIE, HK .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (03) :409-416
[10]   SINGLE DOSE KINETICS OF DEUTERIUM LABELED DELTA-1-TETRAHYDROCANNABINOL IN HEAVY AND LIGHT CANNABIS USERS [J].
OHLSSON, A ;
LINDGREN, JE ;
WAHLEN, A ;
AGURELL, S ;
HOLLISTER, LE ;
GILLESPIE, HK .
BIOMEDICAL MASS SPECTROMETRY, 1982, 9 (01) :6-10